Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
2001 1
2003 1
2004 1
2005 3
2006 1
2007 1
2008 1
2009 2
2011 3
2012 1
2014 1
2015 2
2016 3
2017 1
2019 1
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
Post-Neoadjuvant Treatment Strategies in Breast Cancer.
Matuschek C, Jazmati D, Bölke E, Tamaskovics B, Corradini S, Budach W, Krug D, Mohrmann S, Ruckhäberle E, Fehm T, Nestle Krämling C, Dommach M, Haussmann J. Matuschek C, et al. Among authors: nestle kramling c. Cancers (Basel). 2022 Feb 28;14(5):1246. doi: 10.3390/cancers14051246. Cancers (Basel). 2022. PMID: 35267554 Free PMC article. Review.
Role of Breast Surgery in BRCA Mutation Carriers.
Nestle-Krämling C, Kühn T. Nestle-Krämling C, et al. Breast Care (Basel). 2012 Oct;7(5):378-82. doi: 10.1159/000343717. Breast Care (Basel). 2012. PMID: 24647776 Free PMC article. Review.
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, González-Martin A, Gargiulo P, Lück HJ, Genestie C; PAOLA-1 investigators; Ray-Coquard I, Pujade-Lauraine E, Vaur D. Leman R, et al. Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer.
Haussmann J, Budach W, Nestle-Krämling C, Wollandt S, Tamaskovics B, Corradini S, Bölke E, Krug D, Fehm T, Ruckhäberle E, Audretsch W, Jazmati D, Matuschek C. Haussmann J, et al. Among authors: nestle kramling c. Cancers (Basel). 2022 Aug 20;14(16):4031. doi: 10.3390/cancers14164031. Cancers (Basel). 2022. PMID: 36011025 Free PMC article.
Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation.
Jazmati D, Bölke E, Halfmann K, Tamaskovics B, Ruckhäberle E, Fehm T, Hoffmann J, Krug D, Nestle Krämling C, Corradini S, Budach W, Mohrmann S, Haussmann J, Matuschek C. Jazmati D, et al. Among authors: nestle kramling c. Cancers (Basel). 2022 Jul 26;14(15):3636. doi: 10.3390/cancers14153636. Cancers (Basel). 2022. PMID: 35892894 Free PMC article.
[Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].
Nestle-Krämling C, Bölke E, Budach W, Peiper M, Niederacher D, Janni W, Eisenberger CF, Knoefel WT, Scherer A, Baldus SE, Lammering G, Gerber PA, Matuschek C. Nestle-Krämling C, et al. Strahlenther Onkol. 2011 Oct;187(10):656-64. doi: 10.1007/s00066-011-2251-5. Epub 2011 Aug 16. Strahlenther Onkol. 2011. PMID: 21858416 Review. German.
32 results